Newron Pharmaceuticals SpA - Company Profile
Powered by
All the data and insights you need on Newron Pharmaceuticals SpA in one report.
$295
- Save hours of research time and resources with
our up-to-date Newron Pharmaceuticals SpA Strategy Report
- Understand Newron Pharmaceuticals SpA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Newron Pharmaceuticals SpA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
14 Mar 2024 | Newron Pharma to Raise Approximately USD6.01 Million in Private Placement of Shares | Equity Offering | - |
Newron Pharmaceuticals SpA |
12 Nov 2021 | Newron Pharmaceuticals SpA Enters Phase II/III Clinical Trial Agreement with Hippocrates Research Srl for evenamide (GDCT0449441) | Contract Service Agreement |
Newron Pharmaceuticals SpA
|
Hippocrates Research Srl
|
06 Sep 2021 | Newron Pharmaceuticals SpA Enters Phase II/III Clinical Trial Agreement with CliniRx Research Pvt Ltd for evenamide (GDCT0417350) | Contract Service Agreement |
Newron Pharmaceuticals SpA
Newron Pharmaceuticals SpA |
CliniRx Research Pvt Ltd
CliniRx Research Pvt Ltd
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer